Efficacy, Safety, and Population Pharmacokinetics of Eltrombopag in Children with Different Severities of Aplastic Anemia

Documenti analoghi

• Population Pharmacokinetics and Dosing Optimization of Piperacillin in Elderly Patients with Pneumonia in the Intensive Care Unit
  di: Jing Sun, et al.
  Pubblicazione: (2025)
• Optimizing Linezolid Dosing in Lung Transplant Recipients: Population Pharmacokinetics, Target Attainment, and Thrombocytopenia Risk Assessment
  di: Dan Zhang, et al.
  Pubblicazione: (2026)
• Comparison of Hetrombopag and Eltrombopag Added to First‐Line Immunosuppressive Therapy in Severe Aplastic Anemia
  di: Baohang Zhang, et al.
  Pubblicazione: (2025)
• Machine Learning Prediction of Unbound Ceftriaxone Concentrations in Children: Capturing Developmental Changes in Protein Binding for Precision Dosing
  di: Bo‐Hao Tang, et al.
  Pubblicazione: (2026)
• Population Pharmacokinetics of Alfentanil in Children
  di: Lorena Medina‐Aymerich, et al.
  Pubblicazione: (2025)